Biomarker testing is vital for all patients with lung cancer, especially younger individuals who have higher rates of actionable mutations. Biomarker testing for patients with lung cancer is critical, ...

The American Lung Association says expanding access to screening and biomarker testing could help improve early diagnosis and ...

The 5-year lung cancer survival rate has increased more than 25% over the past decade, highlighting the impact of increased ...

Campaign aims to improve lung cancer survival through early detection, education and widespread access to biomarker testing. CHICAGO, Aug. 20, 2025 /PRNewswire/ -- For people with lung cancer, ...

Lung cancer remains the leading cause of cancer death, but advances in screening, surgery and personalized treatment are ...

The American Lung Association released its eighth annual State of Lung Cancer report this past week, noting the five-year ...

Med Center Health has been named a Center of Excellence (COE) by GO2 for Lung Cancer (GO2). An estimated 237,000 Americans ...

American Lung Association’s ‘State of Lung Cancer’ report examines burden of lung cancer in Maine and details opportunities to save lives ...

Report finds that only 28.1% of lung cancer cases in Virginia are diagnosed early, when the survival rate is the highest.

Young lung cancer patients have a higher incidence of targetable biomarkers, necessitating comprehensive testing for ALK fusions and EGFR mutations. Repeat biomarker testing is essential when ...

The MarketWatch News Department was not involved in the creation of this content. Campaign aims to improve lung cancer survival through early detection, education and widespread access to biomarker ...